author-photo

Andrew M Wardley

University of Manchester
Manchester Academic Health Science Centre

195

Papers

15545

Citations

Citation Trend

Filter By

Papers (152) Sort By

Journal Conference Others

Genomic profile of advanced breast cancer in circulating tumour DNA.

2021 Nature Communications
Show All
- Source
- Cite
- Save
Citations (3)
Risk-based decision-making in the treatment of HER2-positive early breast cancer: Recommendations based on the current state of knowledge

2021 Cancer Treatment Reviews
Show All
- Source
- Cite
- Save
Citations (0)
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer.

2021 Breast Cancer Research and Treatment
Show All
- Source
- Cite
- Save
Citations (1)
LBA11 Individual patient data meta-analysis of 5 non-inferiority RCTs of reduced duration single agent adjuvant trastuzumab in the treatment of HER2 positive early breast cancer

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Abstract PD13-04: Impact of tucatinib on health-related quality of life in patients with HER2+ metastatic breast cancer with stable and active brain metastases

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Final results from PERUSE, a global study of pertuzumab (P), trastuzumab (H) and investigator’s chosen taxane as first-line therapy for HER2-positive locally recurrent/metastatic breast cancer (LR/mBC)

2021
Show All
- Source
- Cite
- Save
Citations (0)
Author Correction: Genomic profile of advanced breast cancer in circulating tumor DNA.

2021 Nature Communications
Show All
- Source
- Cite
- Save
Citations (16)
Abstract PS5-02: Assessment of early ctDNA dynamics to predict efficacy of targeted therapies in metastatic breast cancer: Results from plasmaMATCH trial

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Six versus 12 months' adjuvant trastuzumab in patients with HER2-positive early breast cancer: the PERSEPHONE non-inferiority RCT.

2020 Health Technology Assessment
Show All
- Source
- Cite
- Save
Citations (1)
Health-related quality of life and work productivity in UK patients with HER2-positive breast cancer: a cross-sectional study evaluating the relationships between disease and treatment stage

2020 Health and Quality of Life Outcomes
Show All
- Source
- Cite
- Save
Citations (2)